Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
Hyo Jung Cho, Sun Hyuk Hwang, Jong Ik Park, et al.
Gut and Liver (2019) Vol. 13, Iss. 4, pp. 440-449
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 9, pp. 599-612
Closed Access | Times Cited: 569
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 962-969
Open Access | Times Cited: 352
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors
Emir Muzurović, Carol Chiung‐Hui Peng, Matthew J. Belanger, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1319-1326
Closed Access | Times Cited: 84
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 71
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Simona Cernea
Life (2024) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies
Phuc Le, Julia Y. Payne, Lu Zhang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 5, pp. 1154-1168
Open Access | Times Cited: 28
Insulin resistance in adipose tissue and fatty liver, but not fat mass, are involved in worsening glycaemic status: The Hiroshima study on glucose metabolism and cardiovascular diseases
Nobuo Sasaki, Yoshitaka Ueno, Ryoji Ozono, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
Daniel J. Cuthbertson, Juha Koskinen, Emily Brown, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 1257-1265
Open Access | Times Cited: 35
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies
Mona Reinshagen, Stefan Kabisch, A. Pfeiffer, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 13
NRF-2 and nonalcoholic fatty liver disease
Arturo Solano-Urrusquieta, José A. Morales‐González, Graciela Castro‐Narro, et al.
Annals of Hepatology (2020) Vol. 19, Iss. 5, pp. 458-465
Open Access | Times Cited: 37
21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
Ian J. Neeland, Takeshi Yokoo, Olof Dahlqvist Leinhard, et al.
JACC. Cardiovascular imaging (2020) Vol. 14, Iss. 2, pp. 482-494
Open Access | Times Cited: 32
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs
Hong Wang, Haibo Tan, Wenjing Zhan, et al.
Journal of Ethnopharmacology (2021) Vol. 274, pp. 114056-114056
Closed Access | Times Cited: 27
SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
Hyo Jung Cho, Eunyoung Lee, Soon Sun Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals
Bin Wang, Mian Li, Zhiyun Zhao, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 5, pp. 1416-1426
Open Access | Times Cited: 24
Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis
Yuting Gao, Tianyi Zhao, Shuoning Song, et al.
Diabetes Research and Clinical Practice (2023) Vol. 200, pp. 110699-110699
Closed Access | Times Cited: 8
Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
Yuping Ding, Quanjun Deng, Mei Yang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3303-3329
Open Access | Times Cited: 8
Pre-Diabetes-Linked miRNA miR-193b-3p Targets PPARGC1A, Disrupts Metabolic Gene Expression Profile and Increases Lipid Accumulation in Hepatocytes: Relevance for MAFLD
Inês G. Mollet, Maria Paula Macedo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3875-3875
Open Access | Times Cited: 7
Features of type 2 diabetes combined with metabolic dysfunction-associated fatty liver disease under conditions of chronic stress
С. М. Ткач, V.І. Pankiv, Z.H. Krushinska
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 1, pp. 18-24
Open Access | Times Cited: 2
Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
Inês C. M. Simões, Justyna Janikiewicz, Judith Bauer, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 2871-2871
Open Access | Times Cited: 22
Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Güallar, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288820-e0288820
Open Access | Times Cited: 6
Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
Federica Tavaglione, Giovanni Targher, Luca Valenti, et al.
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 13
Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study
Seung Min Chung, Min Kyu Kang, Jinho Jung, et al.
Diabetes Research and Clinical Practice (2022) Vol. 184, pp. 109208-109208
Closed Access | Times Cited: 8
Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
Ji Eun Han, Han-Bit Shin, Young-Hwan Ahn, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Diabetes and Non‐alcoholic Fatty Liver Disease
Alessandro Mantovani, Giovanni Targher, Christopher D. Byrne
(2024), pp. 820-837
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top